Mizuho Securities USA LLC Cuts Holdings in Danaher Co. (NYSE:DHR)

Mizuho Securities USA LLC lowered its stake in shares of Danaher Co. (NYSE:DHR) by 18.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,680 shares of the conglomerate’s stock after selling 9,147 shares during the period. Mizuho Securities USA LLC’s holdings in Danaher were worth $11,588,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the business. CarsonAllaria Wealth Management Ltd. acquired a new position in Danaher in the 2nd quarter valued at about $25,000. nVerses Capital LLC purchased a new position in shares of Danaher in the 2nd quarter valued at $25,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Danaher in the 3rd quarter valued at $40,000. MFA Wealth Advisors LLC acquired a new stake in Danaher during the 2nd quarter worth $51,000. Finally, Financial Connections Group Inc. acquired a new stake in Danaher during the 2nd quarter worth $51,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $233.10 on Thursday. Danaher Co. has a 52-week low of $213.61 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a 50 day simple moving average of $259.67 and a 200 day simple moving average of $260.13. The firm has a market capitalization of $168.36 billion, a PE ratio of 44.48, a P/E/G ratio of 4.25 and a beta of 0.85.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the prior year, the business posted $2.02 EPS. The business’s revenue was up 3.1% compared to the same quarter last year. Sell-side analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Insider Activity at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This represents a 18.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 11.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

DHR has been the subject of several recent analyst reports. Stifel Nicolaus raised their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. UBS Group decreased their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. TD Cowen lifted their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Robert W. Baird reduced their target price on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Finally, The Goldman Sachs Group lifted their price target on shares of Danaher from $225.00 to $250.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 24th. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.